July 02, 2024 article Less is more: Exploring neoadjuvant immunotherapy as a de-escalation strategy in head and neck squamous cell carcinoma treatment Cancer Letters DOI: 10.1016/j.canlet.2024.217095 OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 33 References 4 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma 2021 Nature Communications article Medicine Cancer Immunotherapy and Biomarkers Open access 330 citations De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed? 2021 Oral Oncology article Medicine Head and Neck Cancer Studies Open access 61 citations [18F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma 2021 European Journal of Nuclear Medicine and Molecular Imaging article Medicine Medical Imaging Techniques and Applications Open access 42 citations Quantitative Diffusion-Weighted Imaging Analyses to Predict Response to Neoadjuvant Immunotherapy in Patients with Locally Advanced Head and Neck Carcinoma 2022 Cancers article Medicine MRI in cancer diagnosis Open access 16 citations 4 results